Viral Myocarditis: Diagnosis and Treatment
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: closed (1 February 2024) | Viewed by 2058
Special Issue Editor
Interests: mechanisms of immune recognition; cellular and molecular defense mechanisms in infectious diseases; cellular and molecular basis for autoimmune diseases; design and application of novel vaccines
Special Issue Information
Dear Colleagues,
Due to increasingly intensive studies on coxsackievirus group B type 3 (CVB3), viral myocarditis, an inflammatory disease of the myocardium, is now recognized as the major cause of sudden cardiac death in young adults and identified as the primary cause of dilated cardiomyopathy.
To better diagnose and treat viral myocarditis, it is vital to conduct mechanistic studies addressing the antiviral immune responses that could provide clues for identifying novel tools, biomarkers, and therapeutic targets. While endomyocardial biopsy is still the gold standard for diagnosis, comprehensive criteria have been established by integrating imaging and multi-omics data for the evaluation of cardiac function, symptoms, laboratory findings, and the identification of viruses, contributing to non-invasive precision diagnosis. Meanwhile, aside from supportive care and complementary therapeutics, such as corticosteroids and heart medications, Traditional Chinese medicine has shown promise as an alternative therapy for viral myocarditis. Additionally, multiple vaccines and therapeutic antibodies have been developed for the condition.
This Special Issue aims to provide up-to-date mechanistic studies and reviews addressing the disease pathogenesis, diagnostic criteria, and translational therapeutic explorations of viral myocarditis. By shedding new light on the disease, we hope to advance the diagnosis and treatment of viral myocarditis.
Prof. Dr. Sidong Xiong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
